Bristol-Myers Squibb discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

The dip buying was not only seen in equities, but also in bonds. The latter part is more significant.

This downgrade is likely to have a very brief impact, a given where the USD Index already moved, the price moves based on this could already be over.

How is the administration’s call to do 90 deals in 90 days going?

China’s economy was a “mixed bag” in April, due partly to an ongoing property slump and sliding property prices.

The U.S. has $36 trillion in debt and is currently running a deficit of $1.5 trillion per fiscal year.

President Donald Trump’s first overseas trip since returning to the White House turned a lot of heads across the aerospace & defense and semiconductor industries last week.

The EUR/USD pair is trading near the 1.13 zone on Monday, reflecting a strong intraday recovery as the market gains momentum after the European session.

​​​​​​​London stocks declined on Monday, mirroring the downturn in worldwide markets following Moody's downgrade of the U.S. sovereign credit rating.

Until Thursday, we are once again in a data drought this week. In the meantime, there are a few points I want to address, including the very important Moody’s downgrade of US debt.

U.S. government debt has lost its final AAA rating, with Moody’s joining Fitch and Standard and Poor’s in downgrading the bonds of the U.S. by one notch.

JPMorgan Chase foresees an increase in net interest income despite economic uncertainties.

With the S&P 500 up about 23% from its April 7th low and just 3% from the February 19th all-time high, the question of the day is how far can the bulls run before taking a much needed a rest?

U.S. corn planting has been moving along without a hitch, and funds have been getting short ahead of last Monday’s reports (Export Inspections & Crop Progress) from the USDA.

Stocks are firmly lower midday, as Moody's credit rating downgrade continues to weigh on U.S. markets.

Launched on May 18, 1995, the S&P Composite 1500 celebrated its 30th anniversary yesterday. The S&P 1500 Index’s 30th anniversary offers a chance to reflect on its performance, characteristics, and potential applications.

Data show that April’s CPI weighed in at its slowest annual pace since February 2021, pointing to a possible boost for U.S. market sentiment following a turbulent start to 2025. 

SenesTech develops, manufacturers, and distributes non-toxic rodent birth control used to eradicate rodent infestations. The company is experiencing rapid growth and increasing revenues with its innovative products. I rate the company as a Buy.

Stocks are off their recent highs to start the week, and as I surfed “FinTwit” over the weekend in between my charting sessions, I still saw a lot of negativity surrounding the state of markets.

The analysis aims to provide valuable insights into market trends and potential opportunities.